146 related articles for article (PubMed ID: 36414796)
1. Clinical characteristics, risk factors, and outcomes in Chilean triple negative breast cancer patients: a real-world study.
Acevedo F; Walbaum B; Medina L; Merino T; Camus M; Puschel K; Ramírez K; Manzor M; Veglia P; Martinez R; Guerra C; Navarro M; Bauerle C; Dominguez F; Sánchez C
Breast Cancer Res Treat; 2023 Jan; 197(2):449-459. PubMed ID: 36414796
[TBL] [Abstract][Full Text] [Related]
2. Prognostic disparities in young patients based on breast cancer subtype: A population-based study from the SEER database.
Chen B; Zhang X; Liu Y; Wang C
Medicine (Baltimore); 2023 Mar; 102(13):e33416. PubMed ID: 37000095
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of male triple negative breast cancer: A population-based study.
Ghani S; Sochat M; Luo J; Tao Y; Ademuyiwa F
Breast J; 2020 Sep; 26(9):1748-1755. PubMed ID: 32856383
[TBL] [Abstract][Full Text] [Related]
4. Screen-detected breast cancer is associated with better prognosis and survival compared to self-detected/symptomatic cases in a Chilean cohort of female patients.
Walbaum B; Puschel K; Medina L; Merino T; Camus M; Razmilic D; Navarro ME; Dominguez F; Cordova-Delgado M; Pinto MP; Acevedo F; Sánchez C
Breast Cancer Res Treat; 2021 Sep; 189(2):561-569. PubMed ID: 34244869
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?
Agarwal G; Nanda G; Lal P; Mishra A; Agarwal A; Agrawal V; Krishnani N
World J Surg; 2016 Jun; 40(6):1362-72. PubMed ID: 26842691
[TBL] [Abstract][Full Text] [Related]
6. Impact of Detection Method and Age on Survival Outcomes in Triple-Negative Breast Cancer: A Population-Based Cohort Analysis.
Rayson D; Payne JI; Michael JCR; Tsuruda KM; Abdolell M; Barnes PJ
Clin Breast Cancer; 2018 Oct; 18(5):e955-e960. PubMed ID: 29885790
[TBL] [Abstract][Full Text] [Related]
7. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
[No Abstract] [Full Text] [Related]
8. Determinants of Prognosis in Triple-Negative Breast Cancer: Report from a Large Breast Cancer Registry.
Tahmasebi S; Almayali AMJ; Arasteh P; Akrami M; Zangouri V; Arasteh P; Hosseini SM; Salehi Nobandegani A; Asgari A; Sadeghi E; Zahiri L; Talei A
Arch Iran Med; 2021 Apr; 24(4):280-288. PubMed ID: 34196187
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer.
Cho B; Han Y; Lian M; Colditz GA; Weber JD; Ma C; Liu Y
JAMA Oncol; 2021 Jul; 7(7):1016-1023. PubMed ID: 33983438
[TBL] [Abstract][Full Text] [Related]
10. Comparison of outcomes between metaplastic and triple-negative breast cancer patients.
Polamraju P; Haque W; Cao K; Verma V; Schwartz M; Klimberg VS; Hatch S; Niravath P; Butler EB; Teh BS
Breast; 2020 Feb; 49():8-16. PubMed ID: 31675684
[TBL] [Abstract][Full Text] [Related]
11. Neighborhood and racial influences on triple negative breast cancer: evidence from Northeast Ohio.
Eom KY; Berg KA; Joseph NE; Runner K; Tarabichi Y; Khiyami A; Perzynski AT; Sossey-Alaoui K
Breast Cancer Res Treat; 2023 Apr; 198(2):369-381. PubMed ID: 36781520
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of Oncologic Outcomes between Triple-Negative Breast Cancer (TNBC) and Non-TNBC among Patients Treated with Breast-Conserving Therapy.
Kim S; Park HS; Kim JY; Ryu J; Park S; Kim SI
Yonsei Med J; 2016 Sep; 57(5):1192-8. PubMed ID: 27401651
[TBL] [Abstract][Full Text] [Related]
13. Triple-negative breast cancers: Are they always different from nontriple-negative breast cancers? An experience from a tertiary center in India.
; Parshad R; Kazi M; Seenu V; Mathur S; Dattagupta S; Haresh KP
Indian J Cancer; 2017; 54(4):658-663. PubMed ID: 30082553
[TBL] [Abstract][Full Text] [Related]
14. Active behavior of triple-negative breast cancer with adipose tissue invasion: a single center and retrospective review.
Yamaguchi J; Moriuchi H; Ueda T; Kawashita Y; Hazeyama T; Tateishi M; Aoki S; Uchihashi K; Nakamura M
BMC Cancer; 2021 Apr; 21(1):434. PubMed ID: 33879104
[TBL] [Abstract][Full Text] [Related]
15. Histopathological Patterns and Outcomes of Triple-Positive Versus Triple-Negative Breast Cancer: A Retrospective Study at a Tertiary Cancer Center.
Kadi MS; Alhebshi AH; Shabkah AA; Alzahrani WA; Enani GN; Samkari AA; Iskanderani O; Saleem AM; Farsi AH; Trabulsi NH
Cureus; 2023 Jul; 15(7):e42389. PubMed ID: 37621828
[TBL] [Abstract][Full Text] [Related]
16. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.
He X; Ji J; Dong R; Liu H; Dai X; Wang C; Esteva FJ; Yeung SJ
Breast Cancer Res Treat; 2019 Jan; 173(2):329-341. PubMed ID: 30341462
[TBL] [Abstract][Full Text] [Related]
17. Opportunities for improving triple-negative breast cancer outcomes: results of a population-based study.
Rapiti E; Pinaud K; Chappuis PO; Viassolo V; Ayme A; Neyroud-Caspar I; Usel M; Bouchardy C
Cancer Med; 2017 Mar; 6(3):526-536. PubMed ID: 28211614
[TBL] [Abstract][Full Text] [Related]
18. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.
Anders CK; Deal AM; Miller CR; Khorram C; Meng H; Burrows E; Livasy C; Fritchie K; Ewend MG; Perou CM; Carey LA
Cancer; 2011 Apr; 117(8):1602-11. PubMed ID: 21472708
[TBL] [Abstract][Full Text] [Related]
19. Prognosis in triple-negative apocrine carcinomas of the breast: A population-based study.
Wu W; Wu M; Peng G; Shi D; Zhang J
Cancer Med; 2019 Dec; 8(18):7523-7531. PubMed ID: 31642210
[TBL] [Abstract][Full Text] [Related]
20. A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies.
Conte B; Brasó-Maristany F; Hernández AR; Pascual T; Villacampa G; Schettini F; Vidal Losada MJ; Seguí E; Angelats L; Garcia-Fructuoso I; Gómez-Bravo R; Lorman-Carbó N; Paré L; Marín-Aguilera M; Martínez-Sáez O; Adamo B; Sanfeliu E; Fratini B; Falato C; Chic N; Vivancos A; Villagrasa P; Staaf J; Parker JS; Perou CM; Prat A
EBioMedicine; 2024 Apr; 102():105043. PubMed ID: 38447275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]